Understanding current antenatal Hepatitis C testing and care in maternity services in England
Journal of Perinatal Medicine · 2024
DOI: 10.1515/jpm-2023-0508 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Perinatal Medicine, 2024. Verfasst von Amoolya Vusirikala und 8 weiteren Autor:innen. Beteiligte Einrichtung: Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency (UKHSA), London, UK. Hauptthemen laut MEDLINE: Pregnancy Complications, Infectious, Hepatitis C. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Objectives
Universal opt-out antenatal screening for Hepatitis C virus (HCV) is not currently recommened and it is recommended that maternity services offer risk-based testing. We aimed to investigate antenatal HCV testing and adherence to testing guidance.
Methods
A cross-sectional survey was circulated to maternity service providers between November–December 2020 which included testing policy, training for healthcare staff, and management of women found to be HCV positive. Descriptive data are presented.
Results
A total of 75 questionnaires were returned, representing 48 % of English maternity service providers. 87 % of providers reported offering antenatal HCV risk-based testing. Risk factors used to identify pregnant women for testing varied. Less than 15 % of respondents considered women that were ever homeless or with history of incarceraton or from higher HCV prevalence areas as high risk.
Conclusions
Current antenatal HCV testing practices are inadequate and HCV infection likely goes undiagnosed in pregnancy, especially among vulnerable population groups. In the absence of universal antenatal screening, re-framing antenatal HCV risk-based testing and management as a quality improvement initiative and developing HCV specific pathway guidance for maternity units is required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency (UKHSA), London, UK.
- NHS England & NHS Improvement, HCV Elimination, London, UK.
- UKHSA, Infectious Diseases in Pregnancy Screening (IDPS) Programme, London, UK.
ORCID-Profile: Matthew Hibbert
Zitieren
APA
Vusirikala, A., Threadgold, G., Roche, R., Hibbert, M., Simmons, R., Webb, S., Gillyon-Powell, M., Desai, M., & Mandal, S. (2024). Understanding current antenatal Hepatitis C testing and care in maternity services in England. Journal of Perinatal Medicine. https://doi.org/10.1515/jpm-2023-0508
Vancouver
Vusirikala A, Threadgold G, Roche R, Hibbert M, Simmons R, Webb S, et al. Understanding current antenatal Hepatitis C testing and care in maternity services in England. Journal of Perinatal Medicine. 2024. doi:10.1515/jpm-2023-0508
BibTeX
@article{Vusirikala2024,
author = {Vusirikala, Amoolya and Threadgold, Georgia and Roche, Rachel and Hibbert, Matthew and Simmons, Ruth and Webb, Sharon and Gillyon-Powell, Mark and Desai, Monica and Mandal, Sema},
title = {Understanding current antenatal Hepatitis C testing and care in maternity services in England},
journal = {Journal of Perinatal Medicine},
year = {2024},
doi = {10.1515/jpm-2023-0508}
}
EUVIMED